Attorneys general from three states have filed a new challenge in their lawsuit to restrict access to the abortion pill mifepristone in their states to encompass the U.S. Food and Drug Administration’s recent approval of a new generic version of the pill.
Missouri Attorney General Catherine Hanaway said on Nov. 20 that she had filed a new challenge against the FDA’s Sept. 30 approval of the new pill. She is joined by fellow plaintiffs Idaho Attorney General Raúl Labrador and Kansas Attorney General Kris Kobach.
“Mifepristone is sending women to the hospital with life-threatening complications, and yet drug companies continue pushing new versions of it into the market without basic medical safeguards,” Hanaway said in a statement. “Mail-order abortion drugs are dangerous when taken without in-person care, and Missouri will not stand by while manufacturers gamble with women’s lives.”…